Feasability of the Epicheck test in upper urinary tract tumor: Interim analysis of a prospective trial

17/07/2020
Boissier R, Territo A, Gallioli A, Vanacore D, Saitta G, Martinez C, Bevilacqua G, Meneghetti I, Tallè M, Montaño Roca B.E, Gaya J.M, Palou, Breda A.
READ MORE

The diagnostic accuracy of Bladder EpiCheck in high-risk population

17/07/2020
Racioppi M, Di Gianfrancesco L, Ragonese M, Palermo G, Sacco E, Bassi P.F.
READ MORE

Methylation study of the Paris system for reporting urinary (TPS) categories

12/06/2020
Pierconti F, Martini M, Cenci T, Fiorentino V, Sacco E, Bientinesi R, Pugliese D, Lacovelli R, Schinzari G, Maria Larocca L, Bassi P.F
READ MORE

Comparison of 2 new real-time polymerase chain reaction-based urinary markers in the follow-up of patients with non-muscle-invasive bladder cancer

01/05/2020
Trenti E, Pycha S, Mian C, Schwienbacher C, Hanspeter E, Kafka M, Spedicato G, Vjaters E, Degener S, Pycha A, D’Elia C.
READ MORE

Bladder EpiCheck In High-Risk Population

23/01/2020
Bassi P.F. , Gianfrancesco L. , Ragonese M. , Palermo G. , Pierconti F. , Martini M. , Racioppi M.
READ MORE

STAY UPDATED ON THE LATEST NEWS FROM NUCLEIX!

SOCIAL MEDIA

Subscribe to one of our social media channels

close

Subscription Confirmation Required

Go to your email inbox

Go to your email inbox

Go to the inbox of the email
address you just used to sign up.

Open the confirmation email

Open the confirmation email

Find the email sent by us. It has the subject line
“Nucleix: Please Confirm Subscription” and I
sent from “info@nucleix.com”.

Click the confirmation link

Click the confirmation link

Click on the link inside the
email and you’re good to go.

GOT IT !